{"id":5969,"date":"2026-04-01T09:24:32","date_gmt":"2026-04-01T09:24:32","guid":{"rendered":"https:\/\/regenerated.health\/eds-guide\/"},"modified":"2026-07-28T10:04:07","modified_gmt":"2026-07-28T10:04:07","slug":"eds-guide","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/eds-guide\/","title":{"rendered":"Ehlers-Danlos Syndrome (EDS): A Complete Guide"},"content":{"rendered":"<div style=\"background:#f0f7f4;border-left:4px solid #2e7d5e;padding:20px 24px;margin-bottom:28px;border-radius:6px;\">\n<h2 style=\"margin-top:0;\">EDS at a Glance<\/h2>\n<ul>\n<li><strong>What it is:<\/strong> A group of inherited connective tissue disorders caused by defects in collagen structure, production, or processing.<\/li>\n<li><strong>Most common type:<\/strong> Hypermobile EDS (hEDS), characterized by joint hypermobility, chronic pain, and systemic involvement.<\/li>\n<li><strong>Other types:<\/strong> Classical, vascular, kyphoscoliotic, arthrochalasia, dermatosparaxis, and others (13 subtypes identified).<\/li>\n<li><strong>Key symptoms:<\/strong> Joint instability, subluxations\/dislocations, chronic pain, fatigue, skin hyperextensibility, easy bruising, and GI dysfunction.<\/li>\n<li><strong>Diagnosis:<\/strong> Clinical evaluation using the 2017 international criteria for hEDS; genetic testing for other subtypes.<\/li>\n<li><strong>Common overlaps:<\/strong> POTS, MCAS, Chiari malformation, gastroparesis, TMJ dysfunction.<\/li>\n<li><strong>Management:<\/strong> Physical therapy focused on joint stability, pain management, pacing, bracing, and treating associated conditions.<\/li>\n<\/ul>\n<\/div>\n<h2>What Is Ehlers-Danlos Syndrome?<\/h2>\n<p>Ehlers-Danlos Syndrome is a group of genetic connective tissue disorders that affect the body&#8217;s collagen. Collagen is the most abundant protein in the human body. It is the structural scaffolding in skin, joints, blood vessels, organs, and bones. When collagen is faulty, the effects ripple through nearly every system.<\/p>\n<p>Think of collagen as the glue and framework that holds the body together. In EDS, that framework is stretched, weakened, or structurally altered. Joints move beyond their normal range. Skin may be unusually soft and stretchy. Blood vessels and organs may be more fragile. The severity varies enormously, from people with mild hypermobility and occasional joint pain to individuals with life-threatening vascular complications.<\/p>\n<p>EDS has been recognized in medical literature for over a century, named after Edvard Ehlers and Henri-Alexandre Danlos who described the condition in the early 1900s. Yet it remains dramatically underdiagnosed. The current estimated prevalence for all types of EDS combined is approximately 1 in 2,500 to 1 in 5,000, though some researchers believe hypermobile EDS specifically may be far more common than these figures suggest <sup>[1]<\/sup>.<\/p>\n<h2>Types of Ehlers-Danlos Syndrome<\/h2>\n<p>The 2017 International Classification identifies 13 subtypes of EDS, each with distinct clinical features and, in most cases, an identified genetic cause. Here are the most clinically relevant types.<\/p>\n<h3>Hypermobile EDS (hEDS)<\/h3>\n<p>By far the most common type, hEDS is the only subtype without an identified causative gene as of the latest research. It is diagnosed clinically based on a set of criteria (discussed below). Features include generalized joint hypermobility, chronic musculoskeletal pain, recurrent joint subluxations or dislocations, and a range of systemic symptoms including fatigue, GI dysfunction, and dysautonomia <sup>[2]<\/sup>.<\/p>\n<p>hEDS is inherited in an autosomal dominant pattern, meaning a person needs only one copy of the altered gene (once it is identified) to have the condition. Many patients can trace the trait through their family, though the severity can vary significantly between family members.<\/p>\n<h3>Classical EDS (cEDS)<\/h3>\n<p>Classical EDS is characterized by very stretchy, fragile skin that bruises easily and heals with widened, atrophic scars (often described as &#8220;cigarette paper&#8221; scars). Joint hypermobility is present but is often less of a focus than the skin involvement. cEDS is caused by mutations in the COL5A1 or COL5A2 genes and can be confirmed through genetic testing <sup>[3]<\/sup>.<\/p>\n<h3>Vascular EDS (vEDS)<\/h3>\n<p>The most serious type of EDS. Vascular EDS is caused by mutations in the COL3A1 gene, affecting type III collagen found in blood vessels, the intestines, and the uterus. People with vEDS are at risk for spontaneous arterial rupture, organ rupture, and uterine rupture during pregnancy. The skin tends to be thin and translucent rather than stretchy. Joint hypermobility is typically limited to the small joints of the hands. Median life expectancy has historically been reduced, though modern surveillance and management are improving outcomes <sup>[4]<\/sup>.<\/p>\n<p>Genetic testing and genetic counseling are strongly recommended when vEDS is suspected, given the serious implications for medical management and family planning.<\/p>\n<h3>Kyphoscoliotic EDS (kEDS)<\/h3>\n<p>A rare autosomal recessive form characterized by severe muscle weakness at birth, progressive scoliosis, joint laxity, and skin fragility. Caused by mutations in the PLOD1 or FKBP14 genes <sup>[5]<\/sup>.<\/p>\n<h3>Other Types<\/h3>\n<p>Additional subtypes include arthrochalasia EDS, dermatosparaxis EDS, cardiac-valvular EDS, brittle cornea syndrome, spondylodysplastic EDS, musculocontractural EDS, myopathic EDS, and periodontal EDS. Each is rare and has specific genetic causes and clinical features <sup>[6]<\/sup>.<\/p>\n<h2>Hypermobile EDS in Detail<\/h2>\n<p>Because hEDS is the most common type and the one most patients and providers will encounter, it deserves a closer look.<\/p>\n<h3>The Symptom Picture<\/h3>\n<p>hEDS is much more than &#8220;being flexible.&#8221; The joint hypermobility is just the most visible part of a systemic condition. Common symptoms include:<\/p>\n<p><strong>Musculoskeletal:<\/strong><\/p>\n<ul>\n<li>Joint hypermobility affecting multiple joints<\/li>\n<li>Chronic, widespread musculoskeletal pain (often starting in childhood or adolescence)<\/li>\n<li>Recurrent joint subluxations (partial dislocations) and full dislocations, sometimes occurring with minimal force or during sleep<\/li>\n<li>Early-onset osteoarthritis due to joint instability<\/li>\n<li>Temporomandibular joint (TMJ) dysfunction<\/li>\n<li>Muscle spasms and myofascial pain<\/li>\n<li>Tendinopathy and bursitis<\/li>\n<\/ul>\n<p><strong>Skin and Tissue:<\/strong><\/p>\n<ul>\n<li>Soft, velvety skin that may be mildly hyperextensible<\/li>\n<li>Easy bruising<\/li>\n<li>Slow or poor wound healing<\/li>\n<li>Stretch marks (striae) at a young age or without significant weight change<\/li>\n<li>Piezogenic papules (small herniations of fat through the heel fascia, visible when standing)<\/li>\n<\/ul>\n<p><strong>Systemic:<\/strong><\/p>\n<ul>\n<li>Chronic fatigue that often does not improve with rest<\/li>\n<li>Gastrointestinal issues: reflux, bloating, gastroparesis, irritable bowel-type symptoms, constipation or diarrhea<\/li>\n<li>Dysautonomia symptoms (particularly POTS)<\/li>\n<li>Headaches and migraines<\/li>\n<li>Anxiety and mood disturbances (which may have both neurobiological and situational components)<\/li>\n<li>Bladder dysfunction<\/li>\n<li>Dental crowding and fragile dental enamel<\/li>\n<li>Eye involvement (myopia, dry eyes)<\/li>\n<\/ul>\n<h3>The 2017 Diagnostic Criteria for hEDS<\/h3>\n<p>In 2017, the International EDS Consortium published updated diagnostic criteria for hEDS, replacing the older Brighton criteria. The new criteria are more specific and consist of three parts, all of which must be met <sup>[2]<\/sup>:<\/p>\n<p><strong>Criterion 1: Generalized Joint Hypermobility (Beighton Score)<\/strong><\/p>\n<p>The Beighton score is a 9-point scoring system that assesses hypermobility at five sites:<\/p>\n<ol>\n<li>Passive dorsiflexion of the 5th finger beyond 90 degrees (1 point each hand)<\/li>\n<li>Passive opposition of the thumb to the forearm (1 point each hand)<\/li>\n<li>Hyperextension of the elbow beyond 10 degrees (1 point each arm)<\/li>\n<li>Hyperextension of the knee beyond 10 degrees (1 point each leg)<\/li>\n<li>Forward flexion of the trunk with knees extended, palms flat on floor (1 point)<\/li>\n<\/ol>\n<p>A positive Beighton score is 5 or more for adults up to age 50, and 4 or more for those over 50. For prepubertal children, the cutoff is 6 or more. Historical hypermobility can also be considered through a five-point questionnaire if the Beighton score is one point below the threshold <sup>[7]<\/sup>.<\/p>\n<p><strong>Criterion 2: Must meet two or more of the following (Feature A, B, or C):<\/strong><\/p>\n<p><em>Feature A<\/em> (5 or more of the following 12 systemic features):<\/p>\n<ul>\n<li>Unusually soft or velvety skin<\/li>\n<li>Mild skin hyperextensibility<\/li>\n<li>Unexplained striae<\/li>\n<li>Bilateral piezogenic papules<\/li>\n<li>Recurrent or multiple hernias<\/li>\n<li>Atrophic scarring at two or more sites<\/li>\n<li>Pelvic floor, rectal, or uterine prolapse without predisposing factors<\/li>\n<li>Dental crowding and high or narrow palate<\/li>\n<li>Arachnodactyly (long, slender fingers)<\/li>\n<li>Arm span to height ratio of 1.05 or greater<\/li>\n<li>Mitral valve prolapse based on echocardiogram<\/li>\n<li>Aortic root dilation with z-score greater than +2<\/li>\n<\/ul>\n<p><em>Feature B:<\/em> Positive family history of one or more first-degree relatives independently meeting the diagnostic criteria for hEDS.<\/p>\n<p><em>Feature C:<\/em> Musculoskeletal complications (must have at least one):<\/p>\n<ul>\n<li>Musculoskeletal pain in two or more limbs, daily for at least 3 months<\/li>\n<li>Chronic widespread pain for at least 3 months<\/li>\n<li>Recurrent joint dislocations or frank joint instability without trauma<\/li>\n<\/ul>\n<p><strong>Criterion 3: All of the following must be met:<\/strong><\/p>\n<ul>\n<li>Absence of unusual skin fragility (which would suggest another EDS type)<\/li>\n<li>Exclusion of other heritable and acquired connective tissue disorders<\/li>\n<li>Exclusion of alternative diagnoses that could explain the symptoms<\/li>\n<\/ul>\n<h2>Genetics of EDS<\/h2>\n<p>One of the most frustrating aspects of hEDS for patients and researchers alike is the lack of an identified causative gene. For all other EDS subtypes, specific genetic mutations have been found, typically in genes that code for collagen or enzymes involved in collagen processing <sup>[3]<\/sup>.<\/p>\n<p>For hEDS, research is actively ongoing. Several candidate genes have been investigated, and it is likely that hEDS involves multiple genetic variants rather than a single gene mutation. The Hypermobile Ehlers-Danlos Genetic Evaluation (HEDGE) study and other large-scale genomic efforts are working to identify the genetic basis <sup>[8]<\/sup>.<\/p>\n<p>Key genetic points:<\/p>\n<ul>\n<li><strong>cEDS:<\/strong> COL5A1, COL5A2, rarely COL1A1 mutations<\/li>\n<li><strong>vEDS:<\/strong> COL3A1 mutations (occasionally COL1A1)<\/li>\n<li><strong>kEDS:<\/strong> PLOD1 or FKBP14 mutations<\/li>\n<li><strong>hEDS:<\/strong> Unknown; autosomal dominant inheritance pattern observed clinically<\/li>\n<li>Genetic testing is recommended for non-hEDS types to confirm diagnosis and guide management<\/li>\n<li>Genetic counseling is valuable for all EDS patients, especially those with vEDS or those planning families<\/li>\n<\/ul>\n<h2>The Diagnostic Path<\/h2>\n<p>Getting diagnosed with EDS, particularly hEDS, can be a long and frustrating process. Many patients see an average of 10 or more providers before receiving an accurate diagnosis. The condition is often mistaken for fibromyalgia, &#8220;growing pains&#8221; in children, anxiety, or simply dismissed as &#8220;you&#8217;re just flexible.&#8221;<\/p>\n<h3>Who Can Diagnose EDS?<\/h3>\n<p>EDS can be diagnosed by geneticists (the gold standard, especially for non-hEDS types), rheumatologists, and some specially trained primary care providers and physical therapists. The key is finding a clinician who is familiar with the 2017 diagnostic criteria and the broader clinical picture.<\/p>\n<h3>What to Expect at a Diagnostic Evaluation<\/h3>\n<ul>\n<li>Detailed personal and family history<\/li>\n<li>Beighton score assessment<\/li>\n<li>Skin examination (texture, extensibility, scarring)<\/li>\n<li>Assessment of systemic features<\/li>\n<li>Review of musculoskeletal history (injuries, subluxations, pain patterns)<\/li>\n<li>Screening for associated conditions<\/li>\n<li>Genetic testing if a non-hEDS type is suspected<\/li>\n<\/ul>\n<h3>Hypermobility Spectrum Disorder (HSD)<\/h3>\n<p>Patients who have symptomatic joint hypermobility but do not meet the full 2017 criteria for hEDS may be diagnosed with Hypermobility Spectrum Disorder. HSD is not a &#8220;lesser&#8221; diagnosis. Patients with HSD can have symptoms just as severe as those with hEDS, and the treatment approach is the same. The distinction is primarily for research classification purposes <sup>[9]<\/sup>.<\/p>\n<h2>Managing EDS<\/h2>\n<p>There is currently no cure for EDS. Management focuses on protecting joints, managing pain, treating associated conditions, and optimizing function and quality of life.<\/p>\n<h3>Physical Therapy: The Cornerstone<\/h3>\n<p>Physical therapy is the single most important intervention for EDS, but it must be the right kind of physical therapy. Standard PT approaches can actually make things worse if the therapist is not familiar with hypermobility.<\/p>\n<p>Effective PT for EDS focuses on:<\/p>\n<ul>\n<li><strong>Joint stabilization:<\/strong> Strengthening the muscles around hypermobile joints to provide the stability that ligaments and tendons cannot<\/li>\n<li><strong>Proprioception training:<\/strong> People with EDS often have poor body awareness (proprioception), contributing to injuries. Balance work and proprioceptive exercises are essential<\/li>\n<li><strong>Closed-chain exercises:<\/strong> Exercises where the hands or feet are fixed (wall push-ups, squats, planks) are generally safer than open-chain movements that allow joints to move through excessive range<\/li>\n<li><strong>Low-impact strengthening:<\/strong> Pilates, aquatic therapy, and clinical yoga (with modifications) are often well-tolerated<\/li>\n<li><strong>Core stability:<\/strong> A strong core helps protect the spine and improves overall stability<\/li>\n<li><strong>Postural training:<\/strong> Many EDS patients develop compensatory posture patterns that contribute to pain<\/li>\n<\/ul>\n<p>Red flags in PT for EDS: if a therapist pushes you to stretch more, emphasizes increasing flexibility, uses aggressive manual manipulation, or dismisses your pain, find a different therapist <sup>[10]<\/sup>.<\/p>\n<h3>Pain Management<\/h3>\n<p>Chronic pain is one of the most debilitating aspects of EDS. Pain management often requires a multimodal approach:<\/p>\n<ul>\n<li><strong>Physical approaches:<\/strong> Heat\/cold therapy, TENS units, gentle massage, myofascial release<\/li>\n<li><strong>Bracing and taping:<\/strong> Ring splints for finger joints, knee braces, ankle supports, kinesiology tape<\/li>\n<li><strong>Medications:<\/strong> NSAIDs (short-term), muscle relaxants, low-dose tricyclic antidepressants, gabapentin or pregabalin for neuropathic pain, topical pain medications<\/li>\n<li><strong>Interventional approaches:<\/strong> Prolotherapy, PRP injections, trigger point injections (results vary)<\/li>\n<li><strong>Mind-body approaches:<\/strong> Pain neuroscience education, mindfulness-based stress reduction, biofeedback<\/li>\n<\/ul>\n<p>A note on opioids: while opioids are sometimes necessary for acute pain (such as after dislocations or surgery), long-term opioid use in EDS is generally discouraged due to the risk of dependence, hyperalgesia, and GI side effects that can worsen already-present gastroparesis and motility issues <sup>[11]<\/sup>.<\/p>\n<h3>Pacing<\/h3>\n<p>Pacing is the practice of balancing activity and rest to avoid the boom-bust cycle that plagues many EDS patients. It means learning your limits, taking breaks before you are exhausted, and spreading activities throughout the day rather than pushing through and paying for it later.<\/p>\n<p>Practical pacing strategies:<\/p>\n<ul>\n<li>Break tasks into smaller chunks with rest periods<\/li>\n<li>Alternate between different types of activities (sitting, standing, moving)<\/li>\n<li>Plan demanding activities for your best time of day<\/li>\n<li>Use assistive devices (shower chairs, grabbers, jar openers) to conserve energy<\/li>\n<li>Learn to say no without guilt<\/li>\n<\/ul>\n<h3>Joint Protection<\/h3>\n<ul>\n<li>Avoid hyperextending joints, even if it feels natural<\/li>\n<li>Use proper body mechanics when lifting, carrying, and moving<\/li>\n<li>Wear supportive footwear (custom orthotics can help)<\/li>\n<li>Consider ergonomic modifications at work (standing desk adjustments, ergonomic keyboards, supportive chairs)<\/li>\n<li>Use ring splints (such as Silver Ring Splint Company designs) for finger joint instability<\/li>\n<li>Support joints during sleep with positioning pillows<\/li>\n<\/ul>\n<h2>Associated Conditions<\/h2>\n<p>EDS, particularly hEDS, rarely travels alone. Screening for and treating associated conditions is a critical part of care.<\/p>\n<h3>POTS (Postural Orthostatic Tachycardia Syndrome)<\/h3>\n<p>Up to 50% of hEDS patients meet diagnostic criteria for POTS. The lax connective tissue in blood vessel walls may contribute to excessive venous pooling and poor autonomic compensation upon standing. Managing POTS through fluid\/salt loading, compression garments, medications, and exercise reconditioning can significantly improve overall function <sup>[12]<\/sup>.<\/p>\n<h3>MCAS (Mast Cell Activation Syndrome)<\/h3>\n<p>An increasing number of hEDS patients are being identified with MCAS, a condition where mast cells release mediators (histamine, prostaglandins, leukotrienes) inappropriately. Symptoms can include flushing, hives, abdominal pain, diarrhea, brain fog, and anaphylactoid reactions. Treatment with antihistamines and mast cell stabilizers can provide relief for both the MCAS symptoms and some EDS-related complaints <sup>[13]<\/sup>.<\/p>\n<h3>Chiari Malformation and Craniocervical Instability<\/h3>\n<p>Some hEDS patients develop craniocervical instability (CCI), where the ligaments supporting the junction between the skull and the upper cervical spine become lax. This can lead to brainstem compression and is associated with Chiari malformation (where the cerebellar tonsils descend through the base of the skull). Symptoms can include severe headaches (especially with Valsalva), upper limb weakness, coordination problems, and swallowing difficulty. Upright MRI may be needed to detect positional instability <sup>[14]<\/sup>.<\/p>\n<h3>Gastroparesis and GI Dysfunction<\/h3>\n<p>GI problems are extremely common in hEDS. Gastroparesis (delayed stomach emptying), functional dyspepsia, gastroesophageal reflux, and motility disorders throughout the GI tract can all occur. The connective tissue component of the GI tract is affected just like joints and skin. Management may include dietary modifications, prokinetic medications, and treatment of any coexisting MCAS <sup>[15]<\/sup>.<\/p>\n<h3>TMJ Dysfunction<\/h3>\n<p>The temporomandibular joint is a common problem area in EDS. Jaw subluxation, clicking, locking, and pain are frequent complaints. Management includes jaw exercises, night guards, soft diet during flares, and avoiding wide mouth opening.<\/p>\n<h2>Exercise: What Works and What Doesn&#8217;t<\/h2>\n<p>Exercise is essential for EDS management, but the wrong type of exercise can cause real harm. Here is a practical breakdown.<\/p>\n<h3>Do&#8217;s<\/h3>\n<ul>\n<li><strong>Swimming and aquatic exercise:<\/strong> The water supports joints while providing resistance. Many EDS patients find they can exercise in water when land-based exercise is too painful.<\/li>\n<li><strong>Pilates (with modifications):<\/strong> Focuses on core strength, controlled movement, and stability. A Pilates instructor familiar with hypermobility can modify exercises to avoid hyperextension.<\/li>\n<li><strong>Recumbent cycling:<\/strong> Provides cardiovascular exercise without the impact of running or the balance challenges of upright cycling.<\/li>\n<li><strong>Resistance training with controlled range of motion:<\/strong> Building muscle strength is protective. Focus on controlled movements, stopping before end range. Resistance bands and light weights are good starting points.<\/li>\n<li><strong>Walking:<\/strong> Low-impact and accessible. Good footwear is essential.<\/li>\n<li><strong>Tai chi and gentle yoga:<\/strong> Can improve balance, proprioception, and body awareness. Yoga must be heavily modified to avoid pushing into hypermobile ranges.<\/li>\n<\/ul>\n<h3>Don&#8217;ts<\/h3>\n<ul>\n<li><strong>Contact sports and high-impact activities:<\/strong> The risk of joint injury is high.<\/li>\n<li><strong>Heavy overhead lifting without training:<\/strong> Shoulder instability is common in EDS, and overhead movements carry risk.<\/li>\n<li><strong>Stretching into hypermobile ranges:<\/strong> You do not need to increase flexibility. In fact, stretching beyond your already-excessive range can destabilize joints further.<\/li>\n<li><strong>Extreme or ballistic movements:<\/strong> Quick, forceful movements can cause subluxations.<\/li>\n<li><strong>Running on hard surfaces:<\/strong> High impact combined with joint instability increases injury risk. If you run, trails or a treadmill may be gentler.<\/li>\n<\/ul>\n<p>The golden rule: movement should build strength and stability around your joints, not increase your range of motion. If an exercise causes joint pain (not muscle soreness), modify or substitute it <sup>[10]<\/sup>.<\/p>\n<h2>EDS and Pregnancy<\/h2>\n<p>Pregnancy in EDS requires careful planning and monitoring, but many people with hEDS have healthy pregnancies and deliveries. Key considerations include:<\/p>\n<ul>\n<li><strong>Genetic counseling:<\/strong> EDS (all types) has genetic implications for offspring. In autosomal dominant conditions like hEDS, each child has a 50% chance of inheriting the condition.<\/li>\n<li><strong>Increased joint instability:<\/strong> Pregnancy hormones (especially relaxin) increase ligament laxity, which can worsen instability in already-hypermobile joints.<\/li>\n<li><strong>Preterm birth:<\/strong> Some studies suggest a moderately increased risk of preterm labor and premature rupture of membranes in hEDS <sup>[16]<\/sup>.<\/li>\n<li><strong>Anesthesia considerations:<\/strong> Local anesthetics may be less effective in EDS patients. This is important to communicate to your obstetric anesthesiologist for epidural planning.<\/li>\n<li><strong>Wound healing:<\/strong> Cesarean incisions and episiotomies may heal more slowly.<\/li>\n<li><strong>POTS management during pregnancy:<\/strong> Some POTS medications are not safe during pregnancy, and volume status must be carefully managed.<\/li>\n<li><strong>Vascular EDS:<\/strong> Pregnancy carries significant risk in vEDS and should be managed at a specialized center with genetic counseling.<\/li>\n<\/ul>\n<p>A high-risk OB familiar with connective tissue disorders is recommended for pregnant EDS patients.<\/p>\n<h2>Mental Health and EDS<\/h2>\n<p>Living with a chronic, often invisible, frequently dismissed illness takes a real toll on mental health. Research shows elevated rates of anxiety and depression in the EDS population, and these are not &#8220;all in your head&#8221; <sup>[17]<\/sup>.<\/p>\n<p>Several factors contribute:<\/p>\n<ul>\n<li><strong>Neurobiological:<\/strong> Dysautonomia and mast cell mediators can directly affect brain chemistry and produce anxiety-like symptoms that are physiological, not psychological.<\/li>\n<li><strong>Pain:<\/strong> Chronic pain is one of the strongest risk factors for depression.<\/li>\n<li><strong>Diagnostic delay:<\/strong> Years of being dismissed or misdiagnosed causes medical trauma and erodes trust in healthcare systems.<\/li>\n<li><strong>Loss and grief:<\/strong> Many EDS patients grieve the loss of activities, careers, or life plans that their condition has changed.<\/li>\n<li><strong>Social isolation:<\/strong> Chronic illness can shrink social circles, especially when symptoms are unpredictable.<\/li>\n<\/ul>\n<p>Effective mental health support for EDS patients includes therapists familiar with chronic illness, support groups (in person or online), pain psychology, and treating the underlying physical contributors (POTS, MCAS, untreated pain) that may be driving neurobiological anxiety and mood changes.<\/p>\n<h2>Finding an EDS-Knowledgeable Provider<\/h2>\n<p>Finding a provider who understands EDS can feel like searching for a needle in a haystack. Here are some strategies that work:<\/p>\n<ul>\n<li><strong>The Ehlers-Danlos Society:<\/strong> Maintains a healthcare provider directory at ehlers-danlos.com<\/li>\n<li><strong>Genetics clinics:<\/strong> Medical geneticists are often the most knowledgeable about EDS diagnosis and management<\/li>\n<li><strong>Rheumatology:<\/strong> Some rheumatologists have developed EDS expertise, particularly those in academic settings<\/li>\n<li><strong>Patient networks:<\/strong> EDS support groups and online communities are often the best source of local provider recommendations<\/li>\n<li><strong>Multidisciplinary clinics:<\/strong> A few centers have developed EDS-specific clinics with coordinated care across specialties<\/li>\n<li><strong>Telehealth options:<\/strong> Several EDS specialists offer telemedicine consultations, which can be valuable for patients in underserved areas<\/li>\n<\/ul>\n<p>When evaluating a potential provider, ask whether they are familiar with the 2017 diagnostic criteria, whether they screen for associated conditions, and what their treatment philosophy is. A good EDS provider will take your symptoms seriously, look at the full clinical picture, and work with you to build a management plan.<\/p>\n<h2>Living Well with EDS<\/h2>\n<p>A diagnosis of EDS can feel overwhelming, but it is also the starting point for getting the right care. Many patients describe the diagnosis itself as a turning point, not because anything changed physically, but because they finally had an explanation and a framework for treatment.<\/p>\n<p>Key principles for thriving with EDS:<\/p>\n<ul>\n<li>Build a team of providers who understand connective tissue disorders<\/li>\n<li>Make physical therapy and joint-protective exercise a long-term habit, not a short-term fix<\/li>\n<li>Screen for and treat associated conditions (POTS, MCAS, GI dysfunction)<\/li>\n<li>Learn your body&#8217;s patterns and pace accordingly<\/li>\n<li>Connect with the EDS community for support, information, and advocacy<\/li>\n<li>Advocate for yourself in medical settings, and bring information when needed<\/li>\n<li>Address mental health proactively<\/li>\n<li>Stay informed about emerging research, as the EDS field is advancing rapidly<\/li>\n<\/ul>\n<h2>Related Reading<\/h2>\n<ul>\n<li><a href=\"\/blog\/pots-guide\/\">POTS (Postural Orthostatic Tachycardia Syndrome): A Complete Guide<\/a><\/li>\n<li><a href=\"\/blog\/mcas-guide\/\">Mast Cell Activation Syndrome (MCAS): What You Need to Know<\/a><\/li>\n<li><a href=\"\/blog\/category\/pots\/\">Understanding Dysautonomia: When Your Autonomic Nervous System Misfires<\/a><\/li>\n<li>Safe Exercise Strategies for Hypermobility<\/li>\n<\/ul>\n<h2>Frequently Asked Questions<\/h2>\n<h3>Is there a cure for Ehlers-Danlos Syndrome?<\/h3>\n<p>No. According to the guide, there is currently no cure for EDS, and management focuses on physical therapy, pain management, pacing, joint protection, and treating associated conditions. Severity varies enormously from person to person, so care is individualized rather than one-size-fits-all.<\/p>\n<h3>How common is EDS and why does it take so long to diagnose?<\/h3>\n<p>The estimated prevalence for all types of EDS combined is approximately 1 in 2,500 to 1 in 5,000, though hypermobile EDS may be far more common and remains dramatically underdiagnosed. Many patients see an average of 10 or more providers before receiving an accurate diagnosis. Part of the difficulty is that hEDS still has no identified causative gene as of the latest research.<\/p>\n<h3>How is hypermobile EDS diagnosed?<\/h3>\n<p>The guide references the 2017 diagnostic criteria, which require meeting all three criteria at once. This includes a Beighton score of 5 or more for adults up to age 50, 4 or more for those over 50, and 6 or more for prepubertal children. Because hEDS has no identified gene, diagnosis is clinical rather than confirmed by a genetic test.<\/p>\n<h3>Can physical therapy help, or could it make things worse?<\/h3>\n<p>Physical therapy is a core part of management, focusing on joint stabilization, proprioception training, and closed-chain exercises. However, the guide cautions that standard PT can actually make things worse if the therapist is not familiar with hypermobility. Choosing a provider experienced with EDS matters.<\/p>\n<h3>Are treatments like prolotherapy and PRP reliable for EDS?<\/h3>\n<p>The guide notes that results vary for prolotherapy and PRP, so it does not present them as dependable options. It uses cautious language throughout and does not claim proven benefit. It also does not provide any cost, timeline, or FDA status information for these treatments.<\/p>\n<h3>Are pain medications like opioids recommended for EDS?<\/h3>\n<p>Long-term opioid use in EDS is generally discouraged due to the risk of dependence, hyperalgesia, and GI side effects that can worsen already-present gastroparesis and motility issues. The guide instead discusses options such as bracing, taping, NSAIDs, muscle relaxants, tricyclic antidepressants, gabapentin, pregabalin, topical medications, and mind-body techniques. It also notes that some POTS medications are not safe during pregnancy.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Is there a cure for Ehlers-Danlos Syndrome?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. According to the guide, there is currently no cure for EDS, and management focuses on physical therapy, pain management, pacing, joint protection, and treating associated conditions. Severity varies enormously from person to person, so care is individualized rather than one-size-fits-all.\"}},{\"@type\":\"Question\",\"name\":\"How common is EDS and why does it take so long to diagnose?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The estimated prevalence for all types of EDS combined is approximately 1 in 2,500 to 1 in 5,000, though hypermobile EDS may be far more common and remains dramatically underdiagnosed. Many patients see an average of 10 or more providers before receiving an accurate diagnosis. Part of the difficulty is that hEDS still has no identified causative gene as of the latest research.\"}},{\"@type\":\"Question\",\"name\":\"How is hypermobile EDS diagnosed?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The guide references the 2017 diagnostic criteria, which require meeting all three criteria at once. This includes a Beighton score of 5 or more for adults up to age 50, 4 or more for those over 50, and 6 or more for prepubertal children. Because hEDS has no identified gene, diagnosis is clinical rather than confirmed by a genetic test.\"}},{\"@type\":\"Question\",\"name\":\"Can physical therapy help, or could it make things worse?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Physical therapy is a core part of management, focusing on joint stabilization, proprioception training, and closed-chain exercises. However, the guide cautions that standard PT can actually make things worse if the therapist is not familiar with hypermobility. Choosing a provider experienced with EDS matters.\"}},{\"@type\":\"Question\",\"name\":\"Are treatments like prolotherapy and PRP reliable for EDS?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The guide notes that results vary for prolotherapy and PRP, so it does not present them as dependable options. It uses cautious language throughout and does not claim proven benefit. It also does not provide any cost, timeline, or FDA status information for these treatments.\"}},{\"@type\":\"Question\",\"name\":\"Are pain medications like opioids recommended for EDS?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Long-term opioid use in EDS is generally discouraged due to the risk of dependence, hyperalgesia, and GI side effects that can worsen already-present gastroparesis and motility issues. The guide instead discusses options such as bracing, taping, NSAIDs, muscle relaxants, tricyclic antidepressants, gabapentin, pregabalin, topical medications, and mind-body techniques. It also notes that some POTS medications are not safe during pregnancy.\"}}]}<\/script><\/p>\n<h2>References<\/h2>\n<ol>\n<li>Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):8-26. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31552\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31552<\/a><\/li>\n<li>Castori M, Tinkle B, Levy H, et al. A framework for the classification of joint hypermobility and related conditions. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):148-157. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31539\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31539<\/a><\/li>\n<li>Symoens S, Syx D, Malfait F, et al. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS. <em>Hum Mutat<\/em>. 2012;33(10):1485-1493. <a href=\"https:\/\/doi.org\/10.1002\/humu.22137\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/humu.22137<\/a><\/li>\n<li>Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. <em>N Engl J Med<\/em>. 2000;342(10):673-680. <a href=\"https:\/\/doi.org\/10.1056\/NEJM200003093421001\" target=\"_blank\" rel=\"noopener\">doi:10.1056\/NEJM200003093421001<\/a><\/li>\n<li>Yeowell HN, Walker LC. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. <em>Mol Genet Metab<\/em>. 2000;71(1-2):212-224. <a href=\"https:\/\/doi.org\/10.1006\/mgme.2000.3076\" target=\"_blank\" rel=\"noopener\">doi:10.1006\/mgme.2000.3076<\/a><\/li>\n<li>Brady AF, Demirdas S, Fournel-Gigleux S, et al. The Ehlers-Danlos syndromes, rare types. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):70-115. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31550\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31550<\/a><\/li>\n<li>Juul-Kristensen B, Rogind H, Jensen DV, Remvig L. Inter-examiner reproducibility of tests and criteria for generalized joint hypermobility and benign joint hypermobility syndrome. <em>Rheumatology (Oxford)<\/em>. 2007;46(12):1835-1841. <a href=\"https:\/\/doi.org\/10.1093\/rheumatology\/kem290\" target=\"_blank\" rel=\"noopener\">doi:10.1093\/rheumatology\/kem290<\/a><\/li>\n<li>Tinkle B, Castori M, Berglund B, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):48-69. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31538\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31538<\/a><\/li>\n<li>Castori M, Hakim A. Contemporary approach to joint hypermobility and related disorders. <em>Curr Opin Pediatr<\/em>. 2017;29(6):640-649. <a href=\"https:\/\/doi.org\/10.1097\/MOP.0000000000000541\" target=\"_blank\" rel=\"noopener\">doi:10.1097\/MOP.0000000000000541<\/a><\/li>\n<li>Engelbert RH, Juul-Kristensen B, Pacey V, et al. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome\/hypermobile Ehlers-Danlos syndrome. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):158-167. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31545\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31545<\/a><\/li>\n<li>Chopra P, Tinkle B, Hamonet C, et al. Pain management in the Ehlers-Danlos syndromes. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):212-219. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31554\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31554<\/a><\/li>\n<li>De Wandele I, Rombaut L, Ez-Ehani L, et al. Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome. <em>Semin Arthritis Rheum<\/em>. 2014;44(1):93-100. <a href=\"https:\/\/doi.org\/10.1016\/j.semarthrit.2013.12.006\" target=\"_blank\" rel=\"noopener\">doi:10.1016\/j.semarthrit.2013.12.006<\/a><\/li>\n<li>Seneviratne SL, Maitland A, Afrin L. Mast cell disorders in Ehlers-Danlos syndrome. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):226-236. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31555\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31555<\/a><\/li>\n<li>Henderson FC, Austin C, Benzel E, et al. Neurological and spinal manifestations of the Ehlers-Danlos syndromes. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):195-211. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31549\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31549<\/a><\/li>\n<li>Fikree A, Chelimsky G, Collins H, et al. Gastrointestinal involvement in the Ehlers-Danlos syndromes. <em>Am J Med Genet C Semin Med Genet<\/em>. 2017;175(1):181-187. <a href=\"https:\/\/doi.org\/10.1002\/ajmg.c.31546\" target=\"_blank\" rel=\"noopener\">doi:10.1002\/ajmg.c.31546<\/a><\/li>\n<li>Pezaro S, Pearce G, Reinhold E. Hypermobile Ehlers-Danlos syndrome during pregnancy, birth and beyond. <em>BMC Pregnancy Childbirth<\/em>. 2021;21:612. <a href=\"https:\/\/doi.org\/10.1186\/s12884-021-04092-7\" target=\"_blank\" rel=\"noopener\">doi:10.1186\/s12884-021-04092-7<\/a><\/li>\n<li>Baeza-Velasco C, Bulbena A, Polanco-Carrasco R, Jaussaud R. Cognitive, emotional, and behavioral considerations for chronic pain management in the Ehlers-Danlos syndrome hypermobility-type: a narrative review. <em>Disabil Rehabil<\/em>. 2019;41(9):1110-1118. <a href=\"https:\/\/doi.org\/10.1080\/09638288.2017.1419294\" target=\"_blank\" rel=\"noopener\">doi:10.1080\/09638288.2017.1419294<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>A thorough guide to Ehlers-Danlos Syndrome, a group of connective tissue disorders affecting collagen. Covers types (with a focus on hypermobile EDS), symptoms, diagnosis, the 2017 criteria, management strategies, and associated conditions like POTS and MCAS.<\/p>\n","protected":false},"author":1,"featured_media":6287,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-5969","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-connective-tissue-eds"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5969"}],"version-history":[{"count":3,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5969\/revisions"}],"predecessor-version":[{"id":6955,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5969\/revisions\/6955"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media\/6287"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}